September 2022
Author Information
Penel N(1), Bonvalot S (2), Bimbai A (3), Meurgey A (4), Le Loarer F (5), Salas S (6), Piperno-Neumann S (2), Chevreau C (7), Boudou-Rouquette P (8), Dubray-Longeras P (9), Kurtz J (10), Guillemet C (11), Bompas E (12), Italiano A (5), Le Cesne A (13), Orbach D (14), Thery J (3), Le Deley M (1), Blay J (15), Mir O (16).
(1) Centre Oscar Lambret, Lille, France. (2) Institute Curie, Paris, France. (3) Centre Oscar Lambret, France.(4) Centre Léon Bérard, France. (5) Institut Bergonié, (6) Aix-Marseille University, MARSEILLE, France. (7) University Institute of Cancerology, Toulouse, France. (8) Cochin Hospital, AP-HP, Paris Descartes University, PARIS, France. (9) Centre Jean Perrin, France. (10) ICANS, France. (11) Centre Henri Becquerel, France. (12) Centre René Gaducheau, Saint Herblain, France. (13) Gustave Roussy Cancer Campus, Villejuif, France. (14) Institute Curie, Paris, France, France. (15) Centre Leon Bérard, Univ Claude Bernard, Unicancer, Lyon, France. (16) Gustave Roussy Cancer Institute, Villejuif, France.Bordeaux, France.
Publication
Clin Cancer Res
© Desmoid Tumor Research Foundation (DTRF) | c/o CliftonLarsonAllen LLP, 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677